These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8112509)

  • 1. Pharmacological analysis of the vasodepressor effect of KRN2391 in pithed rats.
    Tanaka Y; Yokoyama T; Kashiwabara T; Fukushima H; Izawa T; Ogawa N
    Gen Pharmacol; 1993 Nov; 24(6):1379-81. PubMed ID: 8112509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological analysis of the effect of KRN2391 on coronary vasculature in perfused rat heart.
    Miwa A; Jinno Y; Yokoyama T; Izawa T; Ogawa N
    Gen Pharmacol; 1994 May; 25(3):471-4. PubMed ID: 7926593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
    Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo K channel-opening effects of Ki3315, a metabolite of the novel vasodilator KRN2391.
    Tanaka Y; Okada Y; Yokoyama T; Nakajima T; Izawa T; Fukushima H; Ogawa N
    Arch Int Pharmacodyn Ther; 1993; 326():62-71. PubMed ID: 8185414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of KRN2391, nitroglycerin and cromakalim in dihydroergotamine-treated pithed rats.
    Kaneta S; Kashiwabara T; Tanaka Y; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Gen Pharmacol; 1994 Sep; 25(5):963-8. PubMed ID: 7835645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
    Yamada H; Yoneyama F; Satoh K; Taira N
    Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of KRN2391 on venous return: comparison with other vasodilators.
    Kaneta S; Jinno Y; Miwa A; Fukushima H; Ogawa N
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):82-8. PubMed ID: 7690101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological analysis of the inhibitory effects of KRN2391 on endothelin-1-induced contraction in isolated large coronary artery of the pig.
    Harada K; Miwa A; Yokoyama T; Izawa T; Ogawa N; Jinno Y
    Gen Pharmacol; 1994 Sep; 25(5):935-9. PubMed ID: 7835640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
    Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of KRN2391, a novel vasodilator, in canine mesenteric artery.
    Ogawa N; Fukata Y; Kaneta S; Jinno Y; Miwa A; Fukushima H
    Jpn J Pharmacol; 1993 Apr; 61(4):303-9. PubMed ID: 8320876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative vasodepressor effects of 3-pyridine derivatives possessing the cyanoamidine or amide structure in pithed rats.
    Kashiwabara T; Nakajima T; Hasegawa S; Tanaka Y; Okada Y; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 328(3):297-306. PubMed ID: 7625884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.
    Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N
    J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of KRN2391 in canine coronary vascular bed.
    Fukata Y; Kaneta S; Okada Y; Yokoyama T; Jinno Y; Fukushima H; Ogawa N
    Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasospasmolytic effect of KRN2391 on 3,4-diaminopyridine-induced rhythmic contraction of porcine coronary artery.
    Miwa A; Takeuchi A; Fukata Y; Izumi H; Izawa T; Ogawa N
    Gen Pharmacol; 1994 Oct; 25(6):1171-8. PubMed ID: 7875541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential vasodilator properties of KRN2391, cromakalim, nitroglycerin and nifedipine in rabbit isolated femoral artery and vein.
    Kashiwabara T; Ogawa N; Izawa T; Fukushima H
    Br J Pharmacol; 1994 Jan; 111(1):278-82. PubMed ID: 8012706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
    Satoh K; Yamada H; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta.
    Kashiwabara T; Nakajima S; Izawa T; Fukushima H; Nishikori K
    Eur J Pharmacol; 1991 Apr; 196(1):1-7. PubMed ID: 1678711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of KRN2391, a novel vasodilator, on endothelin-1-induced contraction of porcine coronary artery: comparison with cromakalim, nitroglycerin and nifedipine.
    Miwa A; Kasai H; Motoki K; Jinno Y; Yokoyama T; Fukushima H; Ogawa N
    Arch Int Pharmacodyn Ther; 1993; 326():52-61. PubMed ID: 8185413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta.
    Kashiwabara T; Nakajima T; Kasai H; Nakajima S; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):175-83. PubMed ID: 7979826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation by KRN2391 and nicorandil of glibenclamide-sensitive K+ channels in Xenopus oocytes.
    Sakuta H; Okamoto K
    Eur J Pharmacol; 1993 Feb; 244(3):277-83. PubMed ID: 8458402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.